Topic: Strategy

Latest content

Disentangling the problem of patent thickets

The Long Read: Biosimilars face far larger patent estates in the US than elsewhere. But when considering the causes of – and potential remedies for – the country’s thicketing phenomenon, the problem turns out to be a thorny one

06 October 2021

Revolutionise your patent process to maximise innovator value, urges GE Research IP chief

Buck de Wolf explains how he overcame his own and others’ scepticism to secure a change of approach that has paid considerable dividends

05 October 2021

Expect a dramatic finale to the Humira patent saga

Saturday Opinion: Alvotech’s speedy infringement trial could see its product jump the queue of adalimumab biosimilars in the final months before AbbVie’s exclusivity comes to an end

02 October 2021

Biopharma IP licensors are getting more money - and earlier - for their innovations

M&A may be stagnant, but innovators are receiving larger upfront payments for partnership agreements

01 October 2021

New Chinese iPhone manufacturer inks patent licence deal with 3M as it continues to face US legal threats

Luxshare has pursued Chinese legal challenges and gotten more involved in dealmaking in response to its first serious patent litigation threat, filed in the US last year

30 September 2021

Nokia’s billion-euro licensing business rests on a quality-focused IP management system

President of Nokia Technologies Jenni Lukander says ISO 9001 certification for portfolio management – believed to be a first for a major in-house patent department – reinforces company’s commitment to patent quality

29 September 2021

A more robust internal licensing market would boost China’s IP development

Saturday Opinion: Recent signs point toward more patent licensing negotiations between Chinese tech companies. That’s good news for the country’s IP system.

25 September 2021

ZTE licensing head: we're actively seeking financial return from our patent portfolio

In an exclusive interview, Marco Tong declines to comment on company’s reported suit against a Chinese phone maker this week, but says ZTE will “reluctantly use enforcement” if implementers “continuously disrespect others’ IP”

24 September 2021

It’s tech, not patents, that makes Qualcomm a royalty-generating machine

The chip giant has built a high-quality portfolio, but it’s world class innovation that ultimately drives the billion-dollar licensing returns each quarter

23 September 2021

FDA seeks USPTO action to tackle patent thicketing

IP policies proposed by the Department of Health miss the mark, but discussions between the two agencies get closer to the nub of the issue

21 September 2021

Get unlimited access to all IAM content